Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible

被引:59
|
作者
Glaumann, Susanne [1 ,2 ]
Nopp, Anna [3 ]
Johansson, S. G. O. [3 ]
Borres, Magnus P. [4 ,5 ]
Nilsson, Caroline [1 ,2 ]
机构
[1] Karolinska Inst, Ctr Allergy Res, Dept Clin Sci & Educ, Stockholm, Sweden
[2] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden
[3] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden
[4] Thermo Fisher Sci, Uppsala, Sweden
[5] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden
来源
PLOS ONE | 2013年 / 8卷 / 01期
关键词
CONTROLLED FOOD CHALLENGES; QUALITY-OF-LIFE; DOUBLE-BLIND; RECOMBINANT ALLERGENS; BASOPHIL ACTIVATION; IGE-SENSITIZATION; COWS MILK; CD-SENS; CHILDREN; DIAGNOSIS;
D O I
10.1371/journal.pone.0053465
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Double-blind placebo-controlled food challenge, DBPCFC, the gold standard for diagnosing food allergy, is time-consuming and potentially dangerous. A basophil allergen threshold sensitivity test, CD-sens, has shown promising results as a diagnostic tool in food allergy. Objectives: To evaluate the reproducibility of oral peanut challenge and compare the outcome to CD-sens in peanut-sensitized children. Methods: Twenty-seven children (4-19 years) underwent a DBPCFC followed by a single-blind oral food-challenge. The peanut challenges (1 mg to 5 g) were evaluated by severity scoring. Blood samples were drawn for CD-sens before the two first challenges. Results: Thirteen children (48%) did not react at any of the challenges. Fourteen reacted at both peanut challenges but not to placebo. Only two of these children reacted at the same threshold dose and with the same severity score. All other children scored differently or reacted at different doses. For children with a positive challenge the geometric mean of the ratio of the doses was 1.834 (p = 0.307) and the arithmetic mean of the difference between the severity scores was 0.143 (p = 0.952). No association was obtained between the two peanut challenges regarding severity score (r(s) = 0.11, p = 0.71) or threshold dose (r(s) = 0.35, p = 0.22). Among the children positive in peanut challenge, 12 were positive in CD-sens. Two were low-responders and could not be evaluated. Geometric mean of the ratio of CD-sens values in children with a positive challenge was 1.035 (p = 0.505) but unlike for the severity score and the threshold dose the association between the two CD-sens values was strong (r(s) = 0.94, P<0.001). Conclusions: For a positive/negative test the reproducibility is 100% for both peanut challenge and CD-sens. However, a comparison of the degree of allergen threshold sensitivity between the two tests is not possible since the threshold dose and severity scoring is not reproducible.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Basophil allergen threshold sensitivity and peanut allergen components in relation to double blind placebo controlled food challenge in children with suspected peanut allergy
    Glaumann, S.
    Nopp, A.
    Rudengren, M.
    Berthold, M.
    Borres, M.
    Lilja, G.
    Johansson, S.
    Nilsson, C.
    [J]. ALLERGY, 2011, 66 : 387 - 388
  • [2] Basophil Allergen Threshold Sensitivity, CD-sens, in Relation to DBPCFC to Peanut in Children with Suspected Peanut Allergy
    Glaumann, S.
    Nilsson, C.
    Lindquist, C.
    Lilja, G.
    Adedoyin, J.
    Borres, M.
    Berthold, M.
    Nopp, A.
    Johansson, S. G. O.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB85 - AB85
  • [3] Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy
    Hourihane, Jonathan O'B.
    Allen, Katrina J.
    Shreffler, Wayne G.
    Dunngalvin, Gillian
    Nordlee, Julie A.
    Zurzolo, Giovanni A.
    Dunngalvin, Audrey
    Gurrin, Lyle C.
    Baumert, Joseph L.
    Taylor, Steve L.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (05) : 1583 - 1590
  • [4] NEW PEANUT ALLERGY IN A CHILD WITH PREVIOUSLY NEGATIVE ORAL PEANUT CHALLENGE
    Dillard, K. H.
    Davis, C. M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A119 - A120
  • [5] Peanut Allergen Powder (Palforzia) for Peanut Allergy
    Erlich, Deborah
    [J]. AMERICAN FAMILY PHYSICIAN, 2022, 105 (01) : 20 - 21
  • [6] Allergen-specific oral immunotherapy for peanut allergy
    Nurmatov, Ulugbek
    Venderbosch, Iris
    Devereux, Graham
    Simons, F. Estelle R.
    Sheikh, Aziz
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [7] Threshold Dose For Peanut Allergy During Peanut Oral Immunotherapy Procedure In Children
    Christie, L.
    Althage, K. A.
    Scurlock, A. M.
    Perry, T. T.
    Pons, L.
    Steele, P.
    Kamilaris, J.
    Jones, S. M.
    Burks, A. W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S77 - S77
  • [8] Peanut Allergen Powder-dnfp: A Novel Oral Immunotherapy to Mitigate Peanut Allergy
    Dougherty, John A.
    Wagner, Justin D.
    Stanton, Megan C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 344 - 353
  • [9] Reproducibility of blinded, oral peanut challenges and basophil allergen threshold sensitivity, CD-sens, in peanut-sensitised children
    Glaumann, S.
    Nopp, A.
    Borres, M.
    Johansson, S.
    Nilsson, C.
    [J]. ALLERGY, 2012, 67 : 156 - 156
  • [10] Oral peanut immunotherapy for children with peanut allergy
    Nash, S. D.
    Steele, P. H.
    Kamilaris, J. S.
    Pons, L.
    Kulis, M. D.
    Lee, L. A.
    Scurlock, A. M.
    Palmer, K. P.
    Perry, T. T.
    Jones, S. M.
    Burks, A. W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S136 - S136